Eureka State News
SEE OTHER BRANDS

Following the news from California

Eureka State News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Eureka State News.

Press releases published on September 5, 2025

Green Rain Energy Holdings Inc. (OTC: GREH) Announces Negotiations for Landmark Renewable Energy Development in Southern California

Green Rain Energy Holdings Inc. (OTC: GREH) Announces Negotiations for Landmark Renewable Energy Development in Southern California

PASADENA, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Green Rain Energy Holdings Inc. (OTC: GREH) (“Green Rain” or the “Company”), a clean-energy company dedicated to reshaping the future of sustainable power, today confirmed that it is in advanced …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June 30, 2025, and provided a corporate update on its progress. …

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment - - 90% of 12-month …

Macerich To Present at BofA Securities 2025 Global Real Estate Conference

Macerich To Present at BofA Securities 2025 Global Real Estate Conference

SANTA MONICA, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) today announced that the Company will present at the BofA Securities 2025 Global Real Estate Conference in New York, NY, on Tuesday, September 9, 2025 at 1:30 p.m. …

JLab Sets New Standards in Headphone Category with the Launch of Industry Leading Battery Replacement Strategy and Innovative Products at IFA 2025

JLab Sets New Standards in Headphone Category with the Launch of Industry Leading Battery Replacement Strategy and Innovative Products at IFA 2025

Carlsbad, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- JLab, a leader in personal technology, is excited to showcase its battery replacement strategy for the EU market and the launch of the JBuds Open headphones and Epic Pods at IFA 2025 in Berlin, Germany. …

MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy

MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy

SAN JOSE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- In August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic Stress Disorder ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions